VB

Vishal Balkrishna Dalbhanjan

Active Director Designated Partner DIN 11356328
DIN 11356328 First appointment Oct 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Vishal Balkrishna Dalbhanjan

Data last updated:

Vishal Balkrishna Dalbhanjan is a Designated Partner at Raxom Pharmaceuticals Llp (since 2025). The company operates in Pharma.

DIN 11356328
Primary Designation Designated Partner
Industry Pharma
First Appointment 27 Oct 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner27 Oct 20252025Active

Board colleagues of Vishal Balkrishna Dalbhanjan

NameDINCompanyDesignation
Sudipa Das11356327Raxom Pharmaceuticals LlpDesignated Partner
Vinay Singh08289389Raxom Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Raxom Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Vishal Balkrishna Dalbhanjan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vishal Balkrishna Dalbhanjan

Vishal Balkrishna Dalbhanjan currently holds 1 directorship: Raxom Pharmaceuticals Llp (Designated Partner, since 27 Oct 2025).

Vishal Balkrishna Dalbhanjan was first appointed on 27 Oct 2025 as Designated Partner at Raxom Pharmaceuticals Llp.

The current boards of Vishal Balkrishna Dalbhanjan's companies include Sudipa Das (Raxom Pharmaceuticals Llp), Vinay Singh (Raxom Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available